Wednesday, December 8, 2021

SPARC inks licensing pact with Visiox Pharma for ophthalmic products

SPARC inks licensing pact with Visiox Pharma for ophthalmic products The company has entered into an agreement with Visiox Pharma LLC (Visiox) to grant exclusive worldwide rights (except for India and Greater China) for the development and commercialisation of PDP-716 and SDN-037, SPARC said in a statement.

from Moneycontrol Business News https://ift.tt/3IumBz4
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Global Market Today: Asian markets temper Iran deal optimism, BOJ decision in view

Asian stocks saw a modest rise, following a rally on news of a peace deal between Iran and the U.S. Investors are now focused on central ban...